Pleased to announce, Jane Chung, Chief Executive Officer, will participate during the 2025 Wells Fargo Healthcare Conference on September 3rd at 2:15PM ET. For more info, https://lnkd.in/gAyZxYwX #WellsFargo2025 #SutroBio #BioNews $STRO
About us
Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro is advancing a robust early-stage pipeline of novel exatecan and dual-payload antibody drug conjugates (ADCs), coupled with high-value collaborations and industry partnerships, which validate its continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.
- Website
-
http://www.sutrobio.com
External link for Sutro Biopharma, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2003
Locations
-
Primary
Get directions
111 Oyster Point Blvd
South San Francisco, California 94080, US
Employees at Sutro Biopharma, Inc.
Updates
-
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates. For more info, https://lnkd.in/g2g5fTv7 #FDA #SutroBio #BioNews $STRO
-
-
Huge thanks to Nature Portfolio and Asher Mullard for the recent article spotlighting Hans-Peter Gerber, CSO at Sutro Biopharma, in the feature: “Dual-Payload ADCs Move into First Oncology Clinical Trials.” The piece offers a thoughtful look at how combining two distinct payloads in a single ADC may unlock new potential in targeted cancer therapies. https://lnkd.in/eGgc4QJK #ADC #CancerResearch #Biotech #Nature #SutroBio $STRO
-
Happy 4th of July! Wishing you a day filled with celebration, reflection, and connection. Stay safe and enjoy the holiday! #SutroBio $STRO #IndependenceDay #July4th 🇺🇸🎇
-
-
At Sutro, we are committed to fostering equity, inclusion, and progress in science and society. #Juneteenth #FreedomDay #EquityInSTEM #SutroBio
-
-
Meet Sutro Biopharma's leadership team at BIO2025, June 16-19 in Boston! Let’s connect through the BIO Partnering™ system and explore how we can drive meaningful change together. #BIO2025
-
-
This PRIDE Month, we celebrate the diversity of our LGBTQ+ community and reaffirm our commitment to fostering an inclusive environment for all. 🌟 Let's continue to stand together, support each other, and champion equality. 🌈 #SutroBio $STRO #PrideMonth #Inclusion #Diversity #Equality #LoveIsLove ❤️🧡💛💚💜💙
-
-
Pleased to announce, Jane Chung, Chief Executive Officer, will participate at the Jefferies Global Healthcare Conference on June 4th at 11:05AM ET. 🔗 Click the link to register and join the live webcast: https://lnkd.in/dj3CYTEn #JefferiesHealthcare #SutroBio $STRO #CancerAwareness #CancerResearch
-
-
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer. For more info, https://lnkd.in/gwaAqsnt #SutroBio $STRO #CancerTherapeutics #CancerResearch
-
-
Excited to announce, Jane Chung, Chief Executive Officer and Hans-Peter Gerber, Chief Scientific Officer will participate at the TD Securities Cowen’s 6th Annual Oncology Innovation Summit on Wednesday, May 28th at 11:00am ET. Click here to register and join the webcast: https://lnkd.in/eYiShXPJ #TDCowen2025 #SutroBio #CancerAwareness #CancerTherapeutics $STRO
-